Published in Am J Hypertens on May 01, 2007
Strain and strain rate imaging by echocardiography - basic concepts and clinical applicability. Curr Cardiol Rev (2009) 1.41
Diagnostic approaches for diabetic cardiomyopathy and myocardial fibrosis. J Mol Cell Cardiol (2009) 0.96
Insulin inhibits cardiac contractility by inducing a Gi-biased β2-adrenergic signaling in hearts. Diabetes (2014) 0.95
Early impairment of contractility reserve in patients with insulin resistance in comparison with healthy subjects. Cardiovasc Diabetol (2013) 0.88
Echocardiography in the assessment of left ventricular longitudinal systolic function: current methodology and clinical applications. Heart Fail Rev (2010) 0.80
Altered myocardial response in patients with diabetic retinopathy: an exercise echocardiography study. Cardiovasc Diabetol (2015) 0.79
Time-course changes in left ventricular myocardial deformation in STZ-induced rabbits on velocity vector imaging. Cardiovasc Ultrasound (2014) 0.78
Myocardial contractility in the stress echo lab: from pathophysiological toy to clinical tool. Cardiovasc Ultrasound (2013) 0.76
Changes in speckle tracking echocardiography measures of ventricular function after percutaneous implantation of the Edwards SAPIEN transcatheter heart valve in the pulmonary position. Echocardiography (2014) 0.76
Cardiac magnetic resonance feature tracking in Kawasaki disease convalescence. Ann Pediatr Cardiol (2017) 0.75
Early diabetic heart disease: just another manifestation of vasculopathy? Am J Hypertens (2007) 0.75
Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J (2011) 10.52
Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial. Lancet (2009) 6.25
ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis (2011) 2.90
Cardiac remodeling in obesity. Circ Cardiovasc Imaging (2013) 2.24
[ESC/EAS Guidelines for the management of dyslipidaemias]. Rev Esp Cardiol (2011) 2.21
Markers of inflammation, metabolic risk factors, and incident heart failure in American Indians: the Strong Heart Study. J Clin Hypertens (Greenwich) (2011) 2.04
Impact of obesity on cardiac geometry and function in a population of adolescents: the Strong Heart Study. J Am Coll Cardiol (2006) 2.00
Initial left-ventricular mass predicts probability of uncontrolled blood pressure in arterial hypertension. J Hypertens (2011) 1.97
Continuous subcutaneous glucose monitoring in diabetic patients: a multicenter analysis. Diabetes Care (2002) 1.92
Cardiac markers of pre-clinical disease in adolescents with the metabolic syndrome: the strong heart study. J Am Coll Cardiol (2008) 1.81
Prognostic effect of inappropriately high left ventricular mass in asymptomatic severe aortic stenosis. Heart (2010) 1.80
Prevalence and prognostic significance of wall-motion abnormalities in adults without clinically recognized cardiovascular disease: the Strong Heart Study. Circulation (2007) 1.78
Relationship between left ventricular geometry and left atrial size and function in patients with systemic hypertension. J Hypertens (2004) 1.65
Improved cardiovascular diagnostic accuracy by pocket size imaging device in non-cardiologic outpatients: the NaUSiCa (Naples Ultrasound Stethoscope in Cardiology) study. Cardiovasc Ultrasound (2010) 1.64
The metabolic syndrome is a risk indicator of microvascular and macrovascular complications in diabetes: results from Metascreen, a multicenter diabetes clinic-based survey. Diabetes Care (2006) 1.60
Is high pulse pressure a marker of preclinical cardiovascular disease? Hypertension (2005) 1.53
Liver fat in obesity: role of type 2 diabetes mellitus and adipose tissue distribution. Eur J Clin Invest (2010) 1.52
Excessive increase in left ventricular mass identifies hypertensive subjects with clustered geometric and functional abnormalities. J Hypertens (2007) 1.52
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis (2011) 1.51
Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study. J Hypertens (2009) 1.48
Comparison of cardiac structure and function in American Indians with and without the metabolic syndrome (the Strong Heart Study). Am J Cardiol (2004) 1.48
Hypertensive target organ damage predicts incident diabetes mellitus. Eur Heart J (2013) 1.47
Clinical impact of 'in-treatment' wall motion abnormalities in hypertensive patients with left ventricular hypertrophy: the LIFE study. J Hypertens (2008) 1.46
Left atrial systolic force in hypertensive patients with left ventricular hypertrophy: the LIFE study. J Hypertens (2008) 1.44
Prognostic value of serial electrocardiographic voltage and repolarization changes in essential hypertension: the HEART Survey study. Am J Hypertens (2007) 1.43
Comparative evaluation of simple indices of insulin resistance. Metabolism (2004) 1.42
[Hypertensive heart disease: diagnostic and therapeutic guidelines]. G Ital Cardiol (Rome) (2008) 1.39
Relations of pulse pressure and other components of blood pressure to preclinical echocardiographic abnormalities. J Hypertens (2002) 1.38
Serial echocardiographic assessment of left ventricular mass: how blinded should readers be? J Hypertens (2004) 1.38
Method errors or unexplained biological information? Hypertension (2010) 1.38
Left ventricular geometry in children with mild to moderate chronic renal insufficiency. J Am Soc Nephrol (2005) 1.36
Incidence of coronary heart disease in type 2 diabetic men and women: impact of microvascular complications, treatment, and geographic location. Diabetes Care (2007) 1.32
Prognostic significance of left ventricular diastolic dysfunction in essential hypertension. J Am Coll Cardiol (2002) 1.31
Normal limits in relation to age, body size and gender of two-dimensional echocardiographic aortic root dimensions in persons ≥15 years of age. Am J Cardiol (2012) 1.29
Cardiovascular and metabolic predictors of progression of prehypertension into hypertension: the Strong Heart Study. Hypertension (2009) 1.26
Different normalizations for body size and population attributable risk of left ventricular hypertrophy: the MAVI study. Am J Hypertens (2005) 1.23
Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study). Eur J Echocardiogr (2008) 1.23
Developing a standard definition of whole-grain foods for dietary recommendations: summary report of a multidisciplinary expert roundtable discussion. Adv Nutr (2014) 1.20
Abdominal adiposity is associated with elevated C-reactive protein independent of BMI in healthy nonobese people. Diabetes Care (2009) 1.18
Impact of diabetes and previous myocardial infarction on long-term survival: 25-year mortality follow-up of primary screenees of the Multiple Risk Factor Intervention Trial. Arch Intern Med (2004) 1.15
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. Eur Heart J (2016) 1.14
Recurrence of cardiovascular events in patients with type 2 diabetes: epidemiology and risk factors. Diabetes Care (2008) 1.14
Fish oil, insulin sensitivity, insulin secretion and glucose tolerance in healthy people: is there any effect of fish oil supplementation in relation to the type of background diet and habitual dietary intake of n-6 and n-3 fatty acids? Nutr Metab Cardiovasc Dis (2006) 1.14
Incidence and risk factors for stroke in type 2 diabetic patients: the DAI study. Stroke (2007) 1.12
Changing the definition of impaired fasting glucose: impact on the classification of individuals and risk definition. Diabetes Care (2005) 1.10
Relation of fibrinogen to cardiovascular events is independent of preclinical cardiovascular disease: the Strong Heart Study. Am Heart J (2003) 1.09
Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients. Lipids Health Dis (2010) 1.09
Skull base reconstruction in the extended endoscopic transsphenoidal approach for suprasellar lesions. J Neurosurg (2007) 1.08
Tuberculum sellae meningiomas: high route or low route? A series of 51 consecutive cases. Neurosurgery (2008) 1.06
Reduced systolic myocardial function in children with chronic renal insufficiency. J Am Soc Nephrol (2007) 1.06
Effects of dietary saturated, monounsaturated and n-3 fatty acids on fasting lipoproteins, LDL size and post-prandial lipid metabolism in healthy subjects. Atherosclerosis (2003) 1.06
Right atrial size and function in patients with pulmonary hypertension associated with disorders of respiratory system or hypoxemia. Eur J Echocardiogr (2006) 1.05
Usefulness of the high triglyceride-to-HDL cholesterol ratio to identify cardiometabolic risk factors and preclinical signs of organ damage in outpatient children. Diabetes Care (2011) 1.05
Vascular effects of improving metabolic control with metformin or rosiglitazone in type 2 diabetes. Diabetes Care (2004) 1.03
Hand-held echocardiography: its use and usefulness. Int J Cardiol (2005) 1.03
Left atrial systolic force and cardiovascular outcome. The Strong Heart Study. Am J Hypertens (2005) 1.03
Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus. Arterioscler Thromb Vasc Biol (2004) 1.02
Endoscopic transnasal resection of anterior cranial fossa meningiomas. Neurosurg Focus (2008) 1.00
Correlates of global area strain in native hypertensive patients: a three-dimensional speckle-tracking echocardiography study. Eur Heart J Cardiovasc Imaging (2012) 1.00
Nebivolol improves coronary flow reserve in hypertensive patients without coronary heart disease. J Hypertens (2004) 1.00
Insufficient control of blood pressure and incident diabetes. Diabetes Care (2009) 0.99
Liver fat is reduced by an isoenergetic MUFA diet in a controlled randomized study in type 2 diabetic patients. Diabetes Care (2012) 0.99
Chronic kidney disease elicits excessive increase in left ventricular mass growth in patients at increased risk for cardiovascular events. J Hypertens (2011) 0.99
Effects of nutraceuticals on prevalence of metabolic syndrome and on calculated Framingham Risk Score in individuals with dyslipidemia. J Hypertens (2010) 0.98
Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in non-diabetic subjects. The GISIR database. Nutr Metab Cardiovasc Dis (2007) 0.98
Lipoprotein particle distribution and size, insulin resistance, and metabolic syndrome in Alaska Eskimos: the GOCADAN study. Atherosclerosis (2008) 0.98
Factor relationships of metabolic syndrome and echocardiographic phenotypes in the HyperGEN study. J Hypertens (2008) 0.97
Extended endoscopic transsphenoidal approach for extrasellar craniopharyngiomas. Neurosurgery (2007) 0.97
Cancer therapy and cardiotoxicity: the need of serial Doppler echocardiography. Cardiovasc Ultrasound (2007) 0.97
Relationship between smoking habits and the features of the metabolic syndrome in a non-diabetic population. Nutr Metab Cardiovasc Dis (2005) 0.96
Anti-remodelling effect of canrenone in patients with mild chronic heart failure (AREA IN-CHF study): final results. Eur J Heart Fail (2009) 0.95
Severe obstructive sleep apnea elicits concentric left ventricular geometry. J Hypertens (2010) 0.95
Coronary flow reserve and myocardial diastolic dysfunction in arterial hypertension. Am J Cardiol (2002) 0.94
Sonographic hepatic-renal ratio as indicator of hepatic steatosis: comparison with (1)H magnetic resonance spectroscopy. Metabolism (2009) 0.94
Exogenous and endogenous postprandial lipid abnormalities in type 2 diabetic patients with optimal blood glucose control and optimal fasting triglyceride levels. J Clin Endocrinol Metab (2004) 0.93
Effects of a plant-based high-carbohydrate/high-fiber diet versus high-monounsaturated fat/low-carbohydrate diet on postprandial lipids in type 2 diabetic patients. Diabetes Care (2009) 0.93
Uncomplicated type 1 diabetes and preclinical left ventricular myocardial dysfunction: insights from echocardiography and exercise cardiac performance evaluation. Diabetes Res Clin Pract (2007) 0.93
Telecare Provides comparable efficacy to conventional self-monitored blood glucose in patients with type 2 diabetes titrating one injection of insulin glulisine-the ELEONOR study. Diabetes Technol Ther (2011) 0.93
Laparoscopic reinforced sleeve gastrectomy: early results and complications. Obes Surg (2011) 0.93
Italian network for obesity and cardiovascular disease surveillance: a pilot project. BMC Fam Pract (2008) 0.93
Gender differences in left ventricular structure and function during antihypertensive treatment: the Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension (2008) 0.93
Association of elevated serum alanine aminotransferase with metabolic factors in obese children: sex-related analysis. Metabolism (2009) 0.93
Myocardial texture in hypertrophic cardiomyopathy. J Am Soc Echocardiogr (2007) 0.93
Determinants of echocardiographic left atrial volume: implications for normalcy. Eur J Echocardiogr (2011) 0.93
Cardiac geometry and function in diabetic or prediabetic adolescents and young adults: the Strong Heart Study. Diabetes Care (2011) 0.92
Independent association of coronary flow reserve with left ventricular relaxation and filling pressure in arterial hypertension. Am J Hypertens (2008) 0.91
Microsurgical anatomic features of the olfactory nerve: relevance to olfaction preservation in the pterional approach. Neurosurgery (2005) 0.91
Predictors of early-stage left ventricular dysfunction in type 2 diabetes: results of DYDA study. Eur J Cardiovasc Prev Rehabil (2011) 0.91
Risk factor-induced cardiovascular remodeling and the effects of angiotensin-converting enzyme inhibitors. J Cardiovasc Pharmacol (2008) 0.91
Ezetimibe beneficially influences fasting and postprandial triglyceride-rich lipoproteins in type 2 diabetes. Atherosclerosis (2011) 0.90
Extended endoscopic endonasal transsphenoidal approach to the suprasellar area: anatomic considerations--part 1. Neurosurgery (2007) 0.90
The "schola medica salernitana": the forerunner of the modern university medical schools. Neurosurgery (2004) 0.90
Perindopril/indapamide combination more effective than enalapril in reducing blood pressure and left ventricular mass: the PICXEL study. J Hypertens (2005) 0.90
Impact of the Pro12Ala polymorphism of the PPAR-gamma2 gene on serum triacylglycerol response to n-3 fatty acid supplementation. Mol Genet Metab (2003) 0.89